Press releases

Eevia Health Plc receives a 226 KSEK / 20 KEUR sales order for a chaga extract

Eevia Health Plc ("Eevia" or "The Company") has received a 20 KEUR sales order for Feno-Chaga®  Organic from a health-food customer in Finland.

The direct customer is a leading super-food company from Finland. It is one of the fastest growing brand owners, with operations in several Nordic countries.

The sales value to Eevia of this new order is c. KEUR 20 EUR. The product is a chaga extract standardized on beta-glucans and polyphenols with immunomodulating effects. Eevia Health is the only company in the world with a clinical study on Chaga extract, for which the company is preparing a scientific manuscript for a peer-reviewed journal. The FENO-CHAGA™ ORGANIC is made from wild-harvested chaga from Finland, a mushroom growing naturally on birch trees. The order is expected to be followed by further repeat orders in the future.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          


Telephone: +358 400 22 5967   


Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn@EeviaHealth.